Abstract: The present invention relates to an aqueous based, solvent free degreaser composition, comprising on a weight basis:a) about 2.5-5.0% of one alcohol alkoxylate with a fatty alcohol moiety selected from the group of compounds having the formula: ##STR1## wherein R is a C.sub.12 to C.sub.15 branched or straight chain alkyl group, m is 1.5, n is 1, o is 9, p is 3.5 and R' is CH.sub.3 ; --CH.sub.2 CH.sub.2 CH.sub.3, and mixtures thereof, R" is --CH.sub.3, --CH.sub.2 CH.sub.3, and mixtures thereof, and R'" is --OH, --CH.sub.3, --O--C.sub.3 -C.sub.18 hydroxyalkyl group and mixtures thereof;b) about 2.5-5.0% of one alkyl phenol alkoxylates of the following formula: ##STR2## wherein R is a C.sub.8 branched or straight chain alkyl group, m is 10 and n is 0 and P represents a phenyl group;c) about 2.5-5.0% of one alkyl oxyothylate of the following formula:R(O CH.sub.2 CH.sub.2).sub.x OHwherein R is a C.sub.12 to C.sub.

Abstract: Aqueous solutions of N-methylmorpholine N-oxide having color numbers below 200 APHA, based on an N-methylmorpholine N-oxide content of 50% by weight, are produced by reacting aqueous hydrogen peroxide solutions with aqueous solutions of N-methylmorpholine having a water content of at least 35% by weight.

Abstract: The present invention encompasses the novel method of using .+-.phenylpropanolamine to induce mucous secretion in the upper airways of persons afflicted with sinusitis or otitis media characterized by retention of thickened respiratory secretions. These methods comprise administering to such person a safe and effective amount of .+-.phenylpropanolamine. It also encompasses certain novel oral compositions consisting essentially of l(-)-norephedrine and a pharmaceutically-acceptable excipient base.

Abstract: The present invention encompasses methods of using 5-phenyl-2-furan esters, amides and ketones and compositions thereof to prevent or limit neuronal death or degeneration in a human or lower animal. These methods comprise systemically administering to such human or other animal a safe and effective amount of a compound of the formula: ##STR1## wherein (1) X is halo or hydrogen, and Y is a substituent selected from the group consisting of unsubstituted or halogen-substituted methyl, halo, nitro, amino, and methoxy; and(2) R is R.sup.1 C(0)OH, R.sup.1 C(0)N(R.sup.3).sub.2, N(R.sup.3).sub.2, OR.sup.1 N(R.sup.3).sub.2, R.sup.1 N(R.sup.3).sub.2, N(R.sup.2)R.sup.1 N(R.sup.3).sub.2, or N(R.sup.2)N(R.sup.3).sub.2 ; whereR.sup.1 is C.sub.1 -C.sub.3 alkyl which is unsubstituted or substituted with C.sub.1 -C.sub.2 alkyl;R.sup.2 is hydrogen or lower alkyl; andeach R.sup.3 is, independently, hydrogen or lower alkyl; orboth R.sup.